ENO1 and cancer: ENO1 is frequently overexpressed in various cancers, driving tumor progression through mechanisms including promotion of glycolysis (Warburg effect), enhanced proliferation, inhibition of apoptosis, facilitation of invasion and metastasis, and adaptation to hypoxic microenvironments [31–33].